Dualsystems Biotech is a Swiss-based biotechnology company founded in 2001, specializing in custom proteomics for industry and academia. The company's proprietary technology, LRC-TriCEPS™, enables the identification of targets and off-targets at the cell membrane on living cells using LC-MS/MS-based methods. This allows for the identification of targets for various ligands including proteins, peptides, viruses, and even small molecules. Additionally, their Flow-TriCEPS ™ technology optimizes binding conditions, enhancing the accuracy of target identification.
There is no investment information
No recent news or press coverage available for Dualsystems Biotech.
We care about your data, and we'd love to use cookies make your experience better.
